Elbit Medical Technologies Ltd (EMTC-M.TA)
ILA 22.9
(27.22%)
ILA 22.9
(27.22%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | - USD | -2098.62% |
| 2022 | -797 Thousand USD | 85.83% |
| 2021 | - USD | -22.98% |
| 2020 | - USD | 80.23% |
| 2019 | - USD | -186.12% |
| 2018 | - USD | 534.13% |
| 2017 | - USD | 60.25% |
| 2016 | - USD | -17.47% |
| 2015 | - USD | -52.01% |
| 2014 | - USD | -26.24% |
| 2013 | - USD | -401.09% |
| 2012 | -1.37 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2024 Q1 | - USD | 100.0% |
| 2023 Q4 | -7.62 Million USD | 0.0% |
| 2023 FY | - USD | -2098.62% |
| 2023 Q1 | -1.13 Million USD | -180.35% |
| 2023 Q2 | -1.13 Million USD | 0.0% |
| 2023 Q3 | -7.62 Million USD | -572.62% |
| 2022 Q4 | -404.5 Thousand USD | 0.0% |
| 2022 FY | - USD | 85.83% |
| 2022 Q3 | -404.5 Thousand USD | 78.4% |
| 2022 Q2 | -1.87 Million USD | 0.0% |
| 2022 Q1 | -1.87 Million USD | 67.23% |
| 2021 Q1 | -1.37 Million USD | 62.75% |
| 2021 Q4 | -5.71 Million USD | 0.0% |
| 2021 Q2 | -1.88 Million USD | -37.35% |
| 2021 Q3 | -5.71 Million USD | -203.53% |
| 2021 FY | - USD | -22.98% |
| 2020 FY | - USD | 80.23% |
| 2020 Q1 | -527 Thousand USD | -128.36% |
| 2020 Q4 | -3.68 Million USD | -1402.45% |
| 2020 Q3 | -245 Thousand USD | 92.85% |
| 2020 Q2 | -3.42 Million USD | -550.47% |
| 2019 Q4 | 1.85 Million USD | 111.95% |
| 2019 Q1 | -467 Thousand USD | -102.04% |
| 2019 Q2 | -8.98 Million USD | -1823.13% |
| 2019 Q3 | -15.54 Million USD | -73.08% |
| 2019 FY | - USD | -186.12% |
| 2018 FY | - USD | 534.13% |
| 2018 Q4 | 22.86 Million USD | 1405.53% |
| 2018 Q3 | 1.51 Million USD | -73.39% |
| 2018 Q2 | 5.7 Million USD | 983.3% |
| 2018 Q1 | 527 Thousand USD | 132.03% |
| 2017 Q3 | -1.64 Million USD | 51.49% |
| 2017 Q1 | -3.39 Million USD | 40.03% |
| 2017 Q2 | -3.39 Million USD | 0.0% |
| 2017 FY | - USD | 60.25% |
| 2017 Q4 | -1.64 Million USD | 0.0% |
| 2016 Q1 | -3.69 Million USD | -138.96% |
| 2016 Q3 | -2.58 Million USD | 29.08% |
| 2016 Q2 | -3.63 Million USD | 1.46% |
| 2016 Q4 | -5.65 Million USD | -119.22% |
| 2016 FY | - USD | -17.47% |
| 2015 Q3 | -126 Thousand USD | 96.7% |
| 2015 Q1 | -4.53 Million USD | -171.84% |
| 2015 Q4 | -1.54 Million USD | -1126.19% |
| 2015 Q2 | -3.81 Million USD | 15.89% |
| 2015 FY | - USD | -52.01% |
| 2014 Q2 | -3.12 Million USD | 33.24% |
| 2014 Q4 | -1.66 Million USD | -307.85% |
| 2014 Q3 | 803 Thousand USD | 125.68% |
| 2014 Q1 | -4.68 Million USD | -137.28% |
| 2014 FY | - USD | -26.24% |
| 2013 Q2 | -2.53 Million USD | 27.91% |
| 2013 FY | - USD | -401.09% |
| 2013 Q4 | -1.97 Million USD | 31.29% |
| 2013 Q3 | -2.87 Million USD | -13.51% |
| 2013 Q1 | -3.51 Million USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|